MondayApr 05, 2021 1:19 pm

Predictive Oncology Inc. (NASDAQ: POAI) Taps Its Chairman to be CEO

Current POAI Chairman J. Melville (“Mel”) Engle has been appointed to CEO position Engle has held executive positions throughout his career at leading pharma and medical device companies, including Dey L.P. (a subsidiary of Merck KGaA), Allergan, Anika Therapeutics and Thermogenesis During his time at Merck’s Dey L.P., Engle transitioned the company from generics to branded products and grew sales from $250 million to $600 million The world today uses big data for all sorts of predictions, especially consumer behavior. One day, though, big data and technology could prove even more valuable as the catalyst to flip the healthcare script…

Continue Reading

ThursdayApr 01, 2021 12:10 pm

Researchers Find That Birth Control Pills May Protect Female Athletes from Concussions

A pilot study that was conducted recently by Northwestern Medicine has discovered that when a female athlete experiences a concussion when the hormone progesterone is at its highest during her menstrual cycle phase, she experiences less stress. Experiencing less stress is a recovery marker while feeling more stress is among the symptoms of a concussion. The study, which was reported in the “Journal of Neurotrauma,” also found that the reason for the neural protection was the increase of the flow of blood to the brain because of higher progesterone levels. Research assistant professor of behavioral sciences and psychiatry from the…

Continue Reading

ThursdayApr 01, 2021 10:48 am

United Medical Equipment Business Solutions Network Inc. Positioned to Assist as Widespread Rapid Testing Gains Momentum

New York City ramps up rapid testing efforts, opens 11 rapid-testing sites; others to follow Mayor notes that low-cost, rapid-testing made available to public is key to accelerating economy's re-opening UME offers rapid -testing kits, provides products and services essential for curbing pandemic and jumpstarting economic recovery United Medical Equipment Business Solutions Network (“UME”), a trusted supplier of COVID-19 antigen and antibody testing kits, is offering a key product that could impede the spread of the virus and speed up economic recovery. A top U.S. testing official announced a scale-up in the country's diagnostic efforts, touting both health and economic…

Continue Reading

WednesdayMar 31, 2021 2:15 pm

Experts Say Vaccines Will Not Be Enough to End COVID-19 Pandemic

As the coronavirus vaccines become more accessible in the United States, two infectious disease experts from Georgetown University Medical Center assert that protecting oneself against the presymptomatic and asymptomatic spread of the SARS-CoV-2 virus, which causes the coronavirus, is the key to ending the pandemic. Both from the Georgetown University Center for Global Health Science and Security, Saskia V. Popescu and Angela L. Rasmussen published their research on the transmission of SARS-CoV-2 without symptoms in the “Science” journal on March 19. The researchers both claim that the symptomless transmission of the virus silently increases the spread of the virus and…

Continue Reading

TuesdayMar 30, 2021 1:30 pm

Research Finds That Covid-19 Infection Increases Chance of Stroke Among Patients

Research conducted recently has discovered that individuals who are hospitalized with coronavirus infections have an increased risk of stroke in comparison with individuals who have similar infectious illnesses such as sepsis and influenza from previous studies. The study found that patients who suffered from ischemic stroke were more likely to suffer from atrial fibrillations, type 2 diabetes, and high blood pressure, as well as come from the Black race, be male and be older. This was in comparison with other coronavirus patients. These findings were presented at this year’s American Stroke Association conference. For their evaluation, the researchers analyzed data…

Continue Reading

TuesdayMar 30, 2021 10:47 am

Healthy Extracts Inc. (HYEX) Leverages the Plant-Based Industry Boon For Continued Revenue Growth

Healthy Extracts Inc. recently declared its 2020 Q4 results showing an exponential revenue increase of 71% from last year The company’s proprietary Fuel4Thought(TM) Brain Booster product is undergoing clinical testing, and is slated for release in Q2 Healthy Extracts, Inc.(TM) officially changed its name from Grey Cloak Tech Inc. on March 1, 2020 Healthy Extracts (OTCQB: HYEX), is a leading researcher and manufacturer of plant-based formulations whose objective is to offer a better lifestyle through superior heart and brain health technology. The company is focused on strengthening and expanding its market reach through its science-based wholly-owned subsidiaries BergaMet North America (BergaMet…

Continue Reading

MondayMar 29, 2021 2:28 pm

Study Finds Cancer Survivors Have Higher Risk of Developing Heart Disease

A study conducted recently discovered that nearly 35% of Americans who have a history with cancer have a higher chance of contracting cardiovascular ailments in the next 10 years, as compared to roughly 23% of Americans who do not have cancer. Researchers from The Ohio State University discovered that the average approximated 10-year risk for an individual who survived cancer was nearly 8%, in comparison with individuals who did not have a cancer history, which was found to be 5%. This was based off of a risk calculator that approximates an individual's 10-year risk of developing stroke or heart disease.…

Continue Reading

MondayMar 29, 2021 12:29 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) New Investor Presentation Shows Value-Added Milestones for Berubicin in 2021

GBM is diagnosed in more than 13,000 people each year in the US, with only a 12–18-month life expectancy Potentially pivotal Phase 2 trial of Berubicin is scheduled to commence around the end of Q1 2021 The company is continuing its pre-clinical work on WP1244 during 2021 and 2022 CNS Pharmaceuticals participated in two virtual conferences during March, spreading awareness about Berubicin and the GBM indicator CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in developing novel treatments for primary and metastatic cancers of the brain and central nervous system, recently announced multiple value-driving milestones for its lead drug candidate…

Continue Reading

MondayMar 29, 2021 11:29 am

Predictive Oncology’s (NASDAQ: POAI) Helomics Exec Talks AI, Big Data and Biology During Podcast Appearance

Convergence of AI, big data and biology allows Helomics to test drugs on living tumor tissue rather than artificial systems Helomics model evaluates multiple measurements in powerful multi-omics approach to cancer research Knowledge encapsulated by Helomics AI is “gold dust,” says chief innovation officer Data, AI and biology come together at Helomics in a way that promises exciting things for the future, according to  Mark Collins, PhD and chief technical officer at the company, which is a subsidiary of Predictive Oncology (NASDAQ: POAI) (https://ibn.fm/ms1hL). Collins was a guest speaker on a DojoLIVE! podcast titled “Can We Cure Cancer with Artificial Intelligence?” where…

Continue Reading

FridayMar 26, 2021 1:00 pm

High Bladder Cancer Treatment Cost Finds Help with Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Technology

Bladder cancer is the 6th most prevalent cancer in the United States and a problem worldwide Bladder cancer is more common in men than women at a 4:1 ratio Bladder cancer treatment has the highest cost per patient over the course of a lifetime because of its greater than 50% recurrence rate Surgeons, including urologists at the University of Washington, have adopted a solution that uses blue light and a contrast agent to better visualize bladder tumors and has been shown to be more successful and reduce costs Imagin Medical has taken this solution one step further by developing the…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000